Earnings History Data for Cara Therapeutics (CARA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Cara Therapeutics

Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics, Inc. is based in Shelton, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
04-03-2024	AH		CARA	Cara Therapeutics	46.00	-0.59	-0.57	0.00	Cara Therapeutics GAAP EPS of -$0.59 misses by $0.23, revenue of $3M misses by $6.13M [3/4/2024 4:02 PM]	0.91	-0.09 (-8.98%)	0.88	-0.12 (-12.02%)	0.50 - 10.28	1,129,572	1,410,000	19,678
Cara Therapeutics GAAP EPS of -$0.59 misses by $0.23, revenue of $3M misses by $6.13M [3/4/2024 4:02 PM]
13-11-2023	AH		CARA	Cara Therapeutics, Inc.	60.03	-0.52	-0.53	-0.43	Cara Therapeutics GAAP EPS of -$0.52 beats by $0.01, revenue of $4.87M misses by $5.08M [11/13/2023 4:02 PM]	1.08	-0.09 (-8.05%)	1.17	-0.01 (-0.85%)	1.02 - 12.81	865,813	430,000	29,698
Cara Therapeutics GAAP EPS of -$0.52 beats by $0.01, revenue of $4.87M misses by $5.08M [11/13/2023 4:02 PM]
07-08-2023	AH		CARA	Cara Therapeutics, Inc.	172.21	-0.58	-0.56	-0.08	Cara Therapeutics GAAP EPS of -$0.58 misses by $0.04, revenue of $6.93M beats by $0.23M [8/7/2023 4:13 PM]	2.92	-0.03 (-0.85%)	2.85	-0.10 (-3.39%)	2.57 - 12.98	1,370,308	710,000	652
Cara Therapeutics GAAP EPS of -$0.58 misses by $0.04, revenue of $6.93M beats by $0.23M [8/7/2023 4:13 PM]
15-05-2023	AH	4:00 PM ET (May 15)	CARA	Cara Therapeutics, Inc.	217.52	-0.49	-0.53	-0.52	Cara Therapeutics GAAP EPS of -$0.49 beats by $0.03, revenue of $6.17M beats by $1.19M [5/15/2023 4:02 PM]	4.45	0.29 (7.11%)	4.25	0.10 (2.41%)	3.89 - 12.98	2,539,675	460,000	9,310
Cara Therapeutics GAAP EPS of -$0.49 beats by $0.03, revenue of $6.17M beats by $1.19M [5/15/2023 4:02 PM]
06-03-2023	AH	4:00 PM ET (Mar 6)	CARA	Cara Therapeutics, Inc.	557.22	-0.56	-0.33	-0.63	Cara Therapeutics GAAP EPS of -$0.56 misses by $0.20, revenue of $3.26M misses by $11.24M [3/6/2023 4:02 PM]	6.59	-3.43 (-34.23%)	7.28	-2.74 (-27.35%)	6.58 - 13.97	5,082,484	400,000	260,121
Cara Therapeutics GAAP EPS of -$0.56 misses by $0.20, revenue of $3.26M misses by $11.24M [3/6/2023 4:02 PM] Cara Therapeutics plummets 29% on quarterly misses; enough cash to operate to H1 2024 [3/6/2023 5:41 PM]
07-11-2022	AH	4:00 PM ET (Nov 7)	CARA	Cara Therapeutics, Inc.	493.74	-0.43	-0.42	-0.02	Cara Therapeutics GAAP EPS of -$0.43 beats by $0.01, revenue of $10.81M beats by $1.95M [11/7/2022 4:04 PM]	9.55	0.21 (2.25%)	9.35	0.01 (0.11%)	7.40 - 18.93	564,191	380,000	690
Cara Therapeutics Q3 2022 Earnings Preview [11/7/2022 12:30 AM] Cara Therapeutics GAAP EPS of -$0.43 beats by $0.01, revenue of $10.81M beats by $1.95M [11/7/2022 4:04 PM] Why Cara Therapeutics (CARA) Might Surprise This Earnings Season [Nov-04-22 08:46AM] Cara Therapeutics (CARA) Reports Q3 Loss, Tops Revenue Estimates [Nov-07-22 05:35PM] Cara Therapeutics Reports Third Quarter 2022 Financial Results [Nov-07-22 04:01PM]
08-08-2022	AH	4:00 PM ET (Aug 8)	CARA	Cara Therapeutics, Inc.	520.37	-0.08	-0.28	-0.61	Cara Therapeutics GAAP EPS of -$0.08 beats by $0.18, revenue of $23M beats by $1.97M [8/8/2022 4:26 PM]	11.82	0.32 (2.78%)	10.95	-0.55 (-4.78%)	7.40 - 18.93	827,138	560,000	2,019
Cara Therapeutics GAAP EPS of -$0.08 beats by $0.18, revenue of $23M beats by $1.97M [8/8/2022 4:26 PM]
09-05-2022	AH	4:00 PM ET (May 9)	CARA	Cara Therapeutics, Inc.	452.85	-0.52	-0.56	-0.47	Cara Therapeutics GAAP EPS of -$0.52 beats by $0.10, revenue of $4.79M beats by $2.53M [5/9/2022 4:03 PM]	9.21	1.76 (23.62%)	7.20	-0.25 (-3.36%)	7.40 - 18.93	2,184,604	750,000	6,923
Cara Therapeutics GAAP EPS of -$0.52 beats by $0.10, revenue of $4.79M beats by $2.53M [5/9/2022 4:03 PM] Cara Therapeutics stock soars after Q1 earnings beat, optimism over Korsuva U.S. launch [5/10/2022 2:38 PM] Cara Therapeutics Reports First Quarter 2022 Financial Results [May-09-22 04:01PM] Cara Therapeutics (CARA) Reports Q1 Loss, Lags Revenue Estimates [May-09-22 05:25PM]
01-03-2022	AH	4:00 PM ET (Mar 1)	CARA	Cara Therapeutics, Inc.	559.18	-0.63	-0.50	1.59	Cara Therapeutics GAAP EPS of -$0.63 misses by $0.11, revenue of $0.82M misses by $0.43M [3/1/2022 4:08 PM]	11.53	1.47 (14.61%)	9.78	-0.28 (-2.78%)	9.63 - 29.65	1,076,198	540,000	1,583
Cara Therapeutics GAAP EPS of -$0.63 misses by $0.11, revenue of $0.82M misses by $0.43M [3/1/2022 4:08 PM] Cara Therapeutics down 8% after hours following Q4 2021 earnings misses [3/1/2022 5:37 PM] Bayer (BAYRY) Earnings & Revenues Surpass Estimates in Q4 [Mar-01-22 09:35AM] Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results [Mar-01-22 04:01PM] Cara Therapeutics (CARA) Reports Q4 Loss, Lags Revenue Estimates [Mar-01-22 05:15PM]
08-11-2021	AH	4:00 PM ET (Nov 8)	CARA	Cara Therapeutics, Inc.	884.09	-0.02	-0.36	-0.35	Cara Therapeutics EPS beats by $0.40, beats on revenue [11/8/2021 4:03 PM]	18.17	0.94 (5.46%)	17.36	0.13 (0.75%)	11.22 - 29.65	1,185,033	1,410,000	3,752
Cara Therapeutics EPS beats by $0.40, beats on revenue [11/8/2021 4:03 PM] Cara Therapeutics shares jump 10% on Q3 earnings beat, cash position update [11/8/2021 4:26 PM] Cara Therapeutics Reports Third Quarter 2021 Financial Results [Nov-08-21 04:01PM] Cara Therapeutics (CARA) Reports Q3 Loss, Tops Revenue Estimates [Nov-08-21 05:15PM] Cara Therapeutics, inc (CARA) Q3 2021 Earnings Call Transcript [Nov-08-21 08:30PM] Cara Therapeutics to Present at Upcoming Investor Conferences [Nov-09-21 04:30PM]
09-08-2021	AH	4:00 PM ET (Aug 9)	CARA	Cara Therapeutics, Inc.	599.12	-0.61	-0.55	-0.54	Cara Therapeutics EPS misses by $0.04 [8/9/2021 4:02 PM]	13.00	0.49 (3.92%)	12.45	-0.06 (-0.48%)	11.22 - 29.65	976,450	600,000	11,916
Cara Therapeutics EPS misses by $0.04 [8/9/2021 4:02 PM] If You Had Bought Cara Therapeutics (NASDAQ:CARA) Shares Five Years Ago You'd Have Earned 107% Returns [Aug-09-21 02:01AM] Cara Therapeutics Reports Second Quarter 2021 Financial Results [Aug-09-21 04:01PM] Cara Therapeutics (CARA) Reports Q2 Loss, Misses Revenue Estimates [Aug-09-21 05:25PM] Cara Therapeutics, inc (CARA) Q2 2021 Earnings Call Transcript [Aug-09-21 09:00PM]
10-05-2021	AH	4:00 PM ET (May 10)	CARA	Cara Therapeutics, Inc.	654.04	-0.47	-0.62	-0.62	Cara Therapeutics EPS beats by $0.12, misses on revenue [5/10/2021 4:05 PM]	13.01	0.63 (5.09%)	12.00	-0.38 (-3.07%)	11.80 - 29.65	980,419	2,570,000	9,935
Cara Therapeutics EPS beats by $0.12, misses on revenue [5/10/2021 4:05 PM] CARA Therapeutics, Inc. to Host Earnings Call [May-10-21 02:30PM] Cara Therapeutics Reports First Quarter 2021 Financial Results [May-10-21 04:01PM] Cara Therapeutics (CARA) Reports Q1 Loss, Misses Revenue Estimates [May-10-21 05:35PM] Cara Therapeutics Inc (CARA) Q1 2021 Earnings Call Transcript [May-10-21 08:30PM]
25-02-2021	AH	4:00 PM ET (Feb 25)	CARA	Cara Therapeutics, Inc.	998.14	1.59	-0.53	-0.61	Cara Therapeutics EPS beats by $1.11, beats on revenue [2/25/2021 4:04 PM]	18.41	-0.85 (-4.41%)	19.40	0.14 (0.73%)	8.88 - 22.60	497,483	577,760	3,066
Cara Therapeutics EPS beats by $1.11, beats on revenue [2/25/2021 4:04 PM] Cara Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results [Feb-25-21 04:01PM]
09-11-2020	AH	4:00 PM ET (Nov 9)	CARA	Cara Therapeutics, Inc.	651.26	-0.35	-0.68	-0.74	Cara Therapeutics EPS beats by $0.24, beats on revenue [11/9/2020 4:04 PM]	15.03	0.52 (3.58%)	15.00	0.49 (3.38%)	8.88 - 26.67	631,229	350,467	2,146

10-08-2020	AH	4:00 PM ET (Aug 10)	CARA	Cara Therapeutics, Inc.	794.60	-0.54	-0.68	-0.58	Cara Therapeutics EPS beats by $0.12, beats on revenue [8/10/2020 4:06 PM]	18.35	1.13 (6.56%)	17.39	0.17 (0.99%)	8.88 - 26.67	583,156	293,027	354